Redox Imbalance: A Core Feature of ME/CFS and Acute COVID-19

Anthony L. Komaroff, MD ME/CFS is defined exclusively by symptoms—subjective experiences that are hard to verify by objective testing. For that reason, since interest in ME/CFS began to grow in the 1980s, scientists have been looking for evidence of underlying objective abnormalities that might explain the symptoms. A recent review, published August 24, 2021, inContinue reading “Redox Imbalance: A Core Feature of ME/CFS and Acute COVID-19”

ME/CFS Research: State of the Art, State of the Science

Written by Dr. Anthony Komaroff On June 7, 2021, Drs. Lipkin and Komaroff published an article in Trends in Molecular Medicine on the state of ME/CFS research in the wake of COVID-19. An illness like ME/CFS has been described in the medical literature for several hundred years.  Yet, when interest in the illness resurfaced inContinue reading “ME/CFS Research: State of the Art, State of the Science”

A Proteomics Study from the Center: Searching for the Criminal

On July 21, 2020, the results of a proteomics study by the Center for Solutions for ME/CFS was published by the journal PLoS ONE. Proteomics uses new technologies—that have become available in the last two decades—to precisely identify large numbers of proteins and measure their levels. The measurement is…